Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qianyang Yuyin granule is a Traditional Chinese Medicine (TCM) compound formulation developed by the Jiangsu Provincial Hospital of Traditional Chinese Medicine. It is primarily indicated for the treatment of hypertension, including high normal blood pressure (prehypertension). The formulation is based on the TCM therapeutic principle of "subduing yang and nourishing yin" (Qianyang Yuyin). Research into its mechanism of action focuses on its ability to modulate the intestinal flora and systemic metabolic networks. By altering the composition of the gut microbiota and influencing small molecule metabolites, the granule aims to regulate blood pressure and prevent the progression of hypertensive disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qianyang yuyin granule.